Propane

Propane

SCHEMBL586967

CCC.CCC.CCC.CCC.S.S

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.44
NFKB1 P19838 1/20 0.44
KCNA1 Q09470 1/20 0.44
KDM4E B2RXH2 1/20 0.40
PMP22 Q01453 1/20 0.40
ATM Q13315 1/20 0.40
ALDH1A1 P00352 2/20 0.38
SLC22A1 O15245 3/20 0.36
LMNA P02545 1/20 0.33
SLC22A2 O15244 1/20 0.31
THRB P10828 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propane SCHEMBL6752484 1.00
Propane SCHEMBL587355 1.00
Propane SCHEMBL28275384 1.00
Propane SCHEMBL27685652 0.91
Propane SCHEMBL9246294 0.89
Propane SCHEMBL1021 0.89
Propane SCHEMBL10956924 0.89 TSHR (0.43) TSHRNFKB1KCNA1KDM4EPMP22
Propane SCHEMBL9248656 0.89 TSHR (0.43) TSHRNFKB1KCNA1KDM4EPMP22
Propane SCHEMBL286506 0.89
Propane SCHEMBL7711629 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8921445-B2 Curable adhesive compositions MITSUI CHEMICALS, INC. (JP) 2014-12-30 US disclosed
US-20130230706-A1 CURABLE ADHESIVE COMPOSITIONS PIXELOPTICS, INC. (US) 2013-09-05 US disclosed
EP-2417210-B1 CURABLE ADHESIVE COMPOSITIONS PIXELOPTICS INC (US) 2013-03-06 EP disclosed
US-8236945-B2 Process for preparing disulfides and thiosulphinates and compounds prepared Universite Joseph Fourier (Grenoble1) (FR) 2012-08-07 US disclosed
EP-2417210-A1 CURABLE ADHESIVE COMPOSITIONS Pixeloptics Inc. (US) 2012-02-15 EP disclosed
WO-2010118421-A1 CURABLE ADHESIVE COMPOSITIONS PIXELOPTICS, INC. (US) 2010-10-14 WO disclosed
US-20100261018-A1 Curable Adhesive Compositions PIXELOPTICS, INC. (US) 2010-10-14 US disclosed
US-20090264637-A1 PROCESS FOR PREPARING DISULPHIDES AND THIOSULPHINATES AND COMPOUNDS PREPARED UNIVERSITE JOSEPH FOURIER (GRENOBLE 1) (FR) 2009-10-22 US disclosed
US-4555315-A High speed copper electroplating process and bath therefor OMI INTERNATIONAL CORPORATION (US) 1985-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264637-A1 PROCESS FOR PREPARING DISULPHIDES AND THIOSULPHINATES AND COMPOUNDS PREPARED TST, STS, MSR1 TSHR 153/4885NFKB1 4003/4885KCNA1 2620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.